2007 to April 2012. The diagnosis of CVST was carried out by neurologists according to the diagnostic criterion published by Bousser et al. 8 To ensure an accurate diagnosis, all three types of brain imaging techniques, including cerebral topography (CT), magnetic resonance imaging (MRI) and magnetic resonance venography (MRV), were performed for each patient. We excluded individuals for whom complete brain imaging (CT, MRI and MRV) was not completed. Due to a lack of equipment, we did not conduct cerebral topography venography (CTV) for any of the patients. In addition, we excluded patients with a history of AED treatment or epilepsy. We also excluded those with any form of severe systematic or neurological diseases. Informed consent was obtained from all patients enrolled in this study after clarifying the terms and conditions as well as the study procedures. Those who refused to complete the informed consent form were not included in the survey. Upon admission, the demographic characteristics of the patients and their previous medical history were recorded. In addition, a complete neurological examination, laboratory tests and further brain imaging were performed to evaluate the following risk factors: gender, age, oral contraceptive use, history of miscarriage, CVST in pregnancy or puerperium, motor deficits, papillary edema, loss of consciousness, thrombophilia, positive vasculitis tests, abnormal hematologic conditions, hemorrhagic lesions indicated by imaging, lesions in different brain tentorial areas (supratentorial or infratentorial), abnormal lesions on imaging in various brain lobes (frontal, temporal, parietal or occipital) and types of sinus thrombosis (sagittal sinus, lateral sinus, transverse sinus, sigmoid sinus, deep sinus and all sinuses). To define the various types of seizures (acute and remote), we applied the method used in a similar study by the Cerebral Venous Thrombosis Portuguese Collaborative Study Group [Venoport] in 2003 [7] . Acute seizures were also divided into ''presenting seizures'', which is the term applied to seizures occurring before diagnosis, and ''early seizures'', which are seizures that occur in the first 2 weeks after diagnosis. Patients were followed-up one month after discharge and attended regular check-ups every 6 months to determine whether they had developed RS. Patients who did not attend scheduled appointments were followed-up through telephone contact.
Patients who experienced more than one remote seizure after discharge were considered to have epilepsy. Anti-epileptic treatment protocols, in terms of the type and dosage of AED, were not identical in all patients who developed seizures.
Statistical analysis
We compared demographic, clinical and imaging factors among patients with or without acute and remote seizures. We applied x 2 tests for bivariate analysis (with Yates's correction when necessary). Student's t-test was used to analyze continuous data. A significant probability value (P value) was considered to be <0.05. To identify seizure predictors, we applied multivariate analysis [logistic-regression analysis (backward model)]. Variables with a significant P value in bivariate analysis were incorporated as predictors in the model. Statistical analyses were performed using SPSS software (version 17).
Results

General information
From April 2007 to April 2012, 95 patients were admitted with the diagnosis of CVST to Al-Zahra Hospital, Isfahan, Iran. During patient retrieval, we excluded one patient due to a history of epilepsy and AED treatment. Ninety-four patients (16 male and 78 female, mean age: 37.19, SD: 11.38) were included in this study, among whom one had experienced CVST for the second time. During hospitalization, 75 of these 94 patients were treated with anticonvulsant drugs. Phenytoin was administered in 58 patients (60.4%), valproate in 19 (19.8%), carbamazepine in 8 (8.3%), phenobarbital in 2 (2.1%) and either lamotrigine or gabapentin in only 1 patient.
After discharge, 63 individuals were followed, whereas others were lost to follow-up. Forty-two patients presented for interview, and 21 were followed-up via phone call, with follow-up lasting for a mean of 28.4 months (median = 27.5 months; range = 1-57 months; one patient with remote seizure died at the end of one month of follow-up). After discharge, of the 63 patients who had been followed-up, 41 were treated with AED. All patients with acute seizure had received AED during hospitalization and were also prescribed AED after discharge. At discharge, 14 patients (21.87%) were being treated with phenytoin, 25 patients (39.06%) with valproate, 10 patients (15.62%) with gabapentin, 4 patients (6.25%) with carbamazepine, 2 patients (3.12%) with lamotrigine and finally 1 with phenobarbital.
Acute seizure characteristics
Of the 94 patients, 32 individuals (34%) experienced at least one seizure based on CVST. Seizures were generalized in 20 patients (21.2%) and focal in 7 patients (7.4%), and both types presented in 5 patients (5.3%). We recorded one patient who developed an episode of status epilepticus during the acute phase. There were 18 patients (19.1%) who experienced a presenting seizure before the diagnosis was confirmed, and 20 individuals (21.3%) had early seizures in the 2 weeks after confirmation of the CVST diagnosis. Six patients (6.3%) had recurrent early seizures after a presenting seizure.
Remote seizure characteristics
Sixty-three individuals were followed-up, whereas 31 patients were unreachable after discharge. Among these 63 patients, 8 (12.6%) faced RS at long-term follow-up (mean: 15th months after onset, range = 1-50, SD = 16.68). Five patients (7.9%) developed RS (first seizure for multiple seizures) during the first year after discharge. In addition, two patients had RS during the 2 months following admission. Only one patient experienced RS during hospitalization. RS were generalized in five patients and focal in two patients, and both types presented in one patient. RS in one patient were subsequent to a cesarean delivery (in the absence of PIH) four years following the development of CVST. In another patient, RS occurred against a background of intracerebral hemorrhage 10 months after discharge. Following discharge, four patients (6.3%) suffered from multiple RS and were diagnosed with epilepsy. In addition, among all patients with RS (eight patients), only one had no history of presenting or early seizures in the acute phase. Of the seven remaining patients (who experienced RS), four presented with a presenting seizure, two were observed to have early seizures and one had developed both presenting and early seizures.
Factors associated with acute seizures (including early and presenting seizures)
Acute seizures were more common in patients with paresis, hemorrhagic lesions indicated by imaging, supratentorial lesions, lesions in the frontal and parietal lobes, thrombophilia and a history of miscarriage (Table 2) . Supratentorial lesions were the most significant factor associated with AS (P value = 0.00, OR: 5.96, CI: 2.22-15.98). Lesions in the parietal lobe were also highly associated with acute phase seizures (P value = 0.00, OR: 5.16, CI: 2-13.29). Twenty-eight patients (29.2%) presented with lesions in only one brain lobe, 14 individuals (14.6%) had lesions in two lobes and 5 (5.2%) had lesions in three lobes. We found that developing lesions that were limited to a single lobe were significantly associated with AS (P = 0.03, OR: 2.88, CI: 1.14-7.25), whereas others with two or three affected brain lobes showed no association. According to logistic multiple regression analysis, no factor was predictive for AS.
Factors associated with remote seizures
Bivariate analysis showed a significant association of RS in patients with loss of consciousness at presentation, supratentorial lesions, lesions in the occipital, temporal and parietal lobes, thrombophilia, AS (early or presenting seizure) and sigmoid sinus thrombosis (Table 1) . Our results indicate that AS was the most (Table 1) .
To identify any possible confounders due to the high attrition rate during follow-up (25 out of 94 patients, 26%), we compared all risk factors among patients who were followed-up and those who were lost to follow-up. Age (P value = 0.01, OR: 0.26, CI: 0.09-0.74) and miscarriage (P value = 0.01, OR: 9.79, CI: 1.24-77.38) differed significantly between the two groups. Subsequent sensitivity analysis showed age as a possible factor associated with RS (P = 0.00, CI: 1.41-8.04) and (P = 0.47, CI: 0.11-2.32). However, having a history of miscarriage was not associated with developing RS (P = 0.21, CI: 0.16-1.39) and (P = 0.07, CI: 0.92-17.90).
Effect on outcome
During our study, seven patients (7.4%) died during hospitalization and one died 2 years after discharge for an unknown reason. Among 32 patients who experienced at least one seizure during our study, the rate of death was 12.5% (4/32), whereas only 6.45% (4/62) of patients without seizures died. We found no relationship between seizure and death (P value = 0.26, OR: 2.07, CI: 0.48-8.89). Neither AS nor RS were discretely associated with mortality rate. Among patients who developed RS, only one died, during the month following CVST onset. There were no deaths due to status epilepticus seizures.
Discussion
Approximately 33% of patients developed seizures in the acute phase of CVST, but only 12.6% experienced RS during subsequent years [most frequently in the first year (7.6%)]. Almost all patients who experienced RS had had a seizure at disease onset. Accordingly, an AS at CVST onset was the factor most strongly associated with seizure development in the long term. On the other hand, supratentorial-parenchymal lesions observed in brain imaging were reported to be strongly associated with both remote and acute seizures. This study represents the first time that supratentorial lesions have been proposed as a strong risk factor for RS. Only a few studies have attempted to determine the predictors of RS. In 2012, Kaila et al. found no predictive factor for long-term seizure development. 11 In another study in 2003, the Venoport group found that AS and hemorrhagic lesions were more common in patients with late seizures. Only hemorrhagic lesions were shown to be a predictive factor for RS by means of logistic regression. 7 AS in our study contributed to RS; in contrast, hemorrhage was not considered to be a significant risk factor for seizures in the chronic phase. However, in our logistic multiple regression analysis, we found no predictor for RS.
Furthermore, we found supratentorial lesions to be associated with RS. This finding is particularly novel because studies such as the Venoport study did not evaluate the role of parenchymal lesions in different tentorial areas in predicting RS. The International Study of Cerebral Vein and Sinus Thrombosis (ISCVT) study, the largest study ever performed regarding acute phase seizures, proposed that supratentorial-parenchymal lesions are the most important predictor for early seizures. Cerebral parenchymal lesions, particularly when located supratentorially, may present cortical involvement with an increased risk of seizures.
Loss of consciousness at CVST onset and thrombophilia are other previously unreported risk factors that were associated with RS in our study. We also evaluated the role of cerebralparenchymal lesions in different brain lobes. Frontal and parietal lobe lesions were associated with Acute seizures, whereas parietal, temporal and occipital lobe lesions were associated with RS seizures. Moreover, the occipital lobe had the most significant association with RS. Only one previous study (Kalita et al.) has evaluated lesions in different brain lobes; no relationship with RS was found, 11 although the authors reported that frontal and parietal lobe lesions were a predictor for presenting seizures. We also found lesions that encompassed multiple brain lobes, which might cause CVST patients to present more RS. However, there was no association between RS and the number of brain lobes affected by parenchymal lesions. As a result and because of the complexity it may cause, the risk of cerebral lesions within multiple brain lobes was ignored.
Among the different types of sinus thrombosis, sigmoid sinus thrombosis was correlated with RS. Thrombosis in other sinuses showed no significant association with AS or RS. The Venoport group also found no relationship between RS and sinus type. 7 Temporal lobe structures are highly sensitive to insults and are commonly involved in epileptogenesis. Hippocampal sclerosis is the most common type of neuropathological damage observed in individuals with temporal lobe epilepsy (TLE).
13,14 Surprisingly, we observed patchy fibrosclerotic tissue distributed widely throughout the brain parenchyma of all patients who experienced remote seizures. Thus, further longitudinal cohorts are needed to evaluate cerebral sclerosis in patients with and without RS. A limitation of our study was the limited number of patients (94 patients), especially patients who experienced RS (8 patients) , and the even smaller number of patients who were followed-up in the long term (63 patients).
To measure the probable attrition bias, we compared different risk factors between followed and unfollowed patients, and found that age and having a history of miscarriage differed significantly. However, only age was found to act as a possible confounder during further analysis. In contrast, previous studies found no evidence that age plays any role in developing any type of seizure. However, it should be noted that our patients were recruited from a single healthcare center, which would eliminate the bias induced by different diagnostic and therapeutic protocols used in different centers.
According to bivariate analysis, there was no significant association between AED prescription and RS. However, the dose, duration or type of antiepileptic drugs were not evaluated in current study. Finally, the confounding effects of AED were inevitable for moral and practical reasons.
Our study provided no evidence that seizures increase the risk of mortality, in contrast to previous observations [5, 7] .
Conclusion
In conclusion, patients with seizures in the acute phase and supratentorial lesions at the time of initial brain imaging are more likely to develop remote seizures after CVST. Other factors such as loss of consciousness, occipital lobe lesions, thrombophilia and sigmoid sinus thrombosis can provide more support for AED administration. Additionally, further studies concerning the role of cerebral fibrosclerosis in predicting RS are strongly recommended. Larger studies should be performed to reassess the predictive factors for RS, and AED administration remains a key issue in CVST management.
